Valvular heart disease associated with long-term treatment by methysergide: a case report.

Abstract	This case report concerns a woman treated continuously since at least 10 years by methysergide for cluster headache. The echocardiographic and histological features of the severe valve fibrosis presented by this patient are very similar to those described with 5 HT(2B) receptors agonistic drugs.
Authors	Michel Andréjak, Catherine Szymanski, Sylvestre Maréchaux, Elise Arnalsteen, Valérie Gras, Jean-Paul Rémadi, Christophe Tribouilloy
Journal	Therapie (Therapie) 2014 May-Jun Vol. 69 Issue 3 Pg. 255-7 ISSN: 0040-5957 [Print] France
PMID	24934823 (Publication Type: Case Reports, Journal Article)
Copyright	© 2014 Société Française de Pharmacologie et de Thérapeutique.
Chemical References	Serotonin Antagonists Methysergide
Topics	Cluster Headache (drug therapy) Female Fibrosis Heart Valve Diseases (chemically induced, physiopathology) Humans Methysergide (administration & dosage, adverse effects) Middle Aged Serotonin Antagonists (administration & dosage, adverse effects) Severity of Illness Index Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!